Pancreatic bile-salt dependent lipase activity in serum of diabetic patients: Is there a relationship with glycation?

Clinical Science

Volumn 94, Issue 2, 1998, Pages 181-188

  Caillol, Nathalie ^b   Pasqualini, Eric ^b   Mas, Eric ^b   Guieu, Régis ^a   Valette, Anne ^b   Boyer, Jean ^b   Lombardo, Dominique ^b  

^a HÔPITAL NORD   (France)

^b INSERM   (France)

Author keywords

Albumin; Bile salt dependent lipase; Diabetes; Glycation

Indexed keywords

BILE SALT; FATTY ACID BINDING PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HUMAN SERUM ALBUMIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

EID: 0031972896     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940181     Document Type: Article

References (46)

1. Lombardo D, Guy O, Figarella C. Purification and characterization of a carboxyl ester hydrolase from human pancreatic juice. Biochim Biophys Acta 1978; 527: 142-9.
2. Lombardo D, Fauvel J, Guy O. Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids. Biochim Biophys Acta 1980; 611: 136-46.
3. Lombardo D, Guy O. Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. II. Action on cholesterol esters and lipid-soluble vitamin esters. Biochim Biophys Acta 1980; 611: 147-55.
4. Baba T, Downs D, Jackson KW, Tang J, Wang CS. Structure of human milk bile salt activated lipase. Biochemistry 1991; 30: 500-10.
5. Chen L, Morin R. Purification of a human placental cholesteryl ester hydrolase. Biochim Biophys Acta 1971; 231: 194-7.
6. Harrison EH. Bile salt-dependent neutral cholesteryl ester hydrolase of rat liver: possible relationship with pancreatic cholesteryl ester hydrolase. Biochim Biophys Acta 1988; 963: 28-34.
7. Kothari HV, Miller BF, Kritchevsky D. Aortic cholesterol esterase: characteristics of normal rat and rabbit enzyme. Biochim Biophys Acta 1973; 296: 446-54.
8. Zolfaghari R, Harrison EH, Ross AC, Fisher EA. Expression in xenopus oocytes of rat liver mRNA coding for a bile salt-dependent cholesteryl ester hydrolase. Proc Natl Acad Sci USA 1989; 84: 6913-16.
9. Camulli ED, Linke MJ, Brockman HL, Hui DY. Identity of a cytosolic neutral cholesterol esterase in rat liver with the bile salt stimulated cholesterol esterase in pancreas. Biochim Biophys Acta 1989; 1005: 177-82.
10. Rea TJ, DeMattos RB, Pape ME. Hepatic expression of genes regulating lipid metabolism in rabbits. J Lipid Res 1993; 34: 1901-10.
11. Lombardo D, Montaldo G, Roudani S, et al. Is bile salt-dependent lipase concentration in serum of any help in pancreatic cancer diagnosis? Pancreas 1993; 8: 581-8.
12. Campbell CB, McGuffie C, Powell LW. The measurement of sulphated and non-sulphated bile acids in serum using gas-liquid chromatography. Clin Chim Acta 1975; 63: 249-62.
13. Angelin B, Björkhem I, Einarsson K, Ewerth S. Hepatic uptake of bile acids in man. J Clin Invest 1982; 70: 724-31.
14. Shamir R, Johnson WJ, Morlock-Fitzpatrick K, et al. Pancreatic carboxyl ester lipase: a circulating enzyme that modifies normal and oxidized lipoproteins in vitro. J Clin Invest 1996; 97: 1696-704.
15. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993; 71: 26-31B.
16. Bucala R, Makita Z, Vega G, et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994; 91: 9441-5.
17. Sasaki J, Cottam GL. Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Acta 1982; 713: 199-207.
18. Steinbrecher UP, Witztum JL. Glycosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 1984; 33: 130-4.
19. Lyons TJ, Klein R, Baynes JW, Stevenson HC, Lopes-Virella MF. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type I (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoprotein. Diabetologia 1987; 30: 916-23.
20. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL. Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 1988; 37: 550-7.
21. Wolff SP, Dean RT. Glucose autoxidation and protein modification: the potential role of 'autoxidative glycosylation' in diabetes mellitus. Biochem J 1987; 245: 243-50.
22. Vaughn M, Virella G, Lopes-Virella MF. Diabetes, autoimmunity, and arteriosclerosis. Clin Immunol Immunopathol 1989; 52: 414-20.
23. Mereish KA, Rosenberg H, Cobby J. Glycosylated albumin and its influence on salicylate binding. J Pharm Sci 1982; 71: 235-8.
24. Hatton MW, Richardson M, Winocour PD. On glucose transport and non enzymatic glycation of proteins in vivo. J Theor Biol 1993; 161: 481-90.
25. Johnson RN, Easdale RW, Tatnell M, Baker JR. Significance of variation in turnover of glycated albumin on indices of diabetic control. Clin Chim Acta 1991; 198: 229-38.
26. Shaklaā N, Garlick RL, Bunn HF. Non enzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 1984; 259: 3812-17.
27. Murtiashaw MH, Winterhalter KH. Non-enzymatic glycation of human albumin does not alter its palmitate binding. Diabetologia 1986; 29: 366-70.
28. Brodersen R, Vorum H, Andersen S. Measurement of palmitate availability in serum samples: method and utility. Chem Phys Lipids 1994; 71: 13-20.
29. Lerique B, Moulin B, Delpero C, Purgus R, Olmer M, Boyer J. High-affinity interaction of long-chain fatty acids with serum albumin in nephrotic syndrome. Clin Sci 1995; 89: 417-20.
30. Brodersen R, Vorum H, Skriver E, Pedersen AO. Serum albumin binding of palmitate and stearate. Multiple binding theory for insoluble ligands. Eur J Biochem 1989; 182: 19-25.
31. Brodersen R, Andersen S, Jacobsen C. Determination of reserve albumin-equivalent for ligand binding, probing two distinct binding functions of the protein. Anal Biochem 1982; 121: 395-408.
32. Brodersen R, Vorum H, Krukow N, Pedersen AO. Binding of long-chain fatty acids to serum albumin in healthy humans. Relationship to obesity. Eur J Biochem 1991; 197: 461-5.
33. Brodersen R, Honoré B, Andersen S. Palmitate binding to serum albumin, measured by rate of dialysis. Eur J Biochem 1988; 174: 45-50.
34. Abouakil N, Rogalska E, Bonicel J, Lombardo D. Purification of pancreatic carboxylic ester hydrolase by immunoaffinity and its application to the human bile salt-stimulated lipase. Biochim Biophys Acta 1988; 961: 299-308.
35. Bruneau N, Lechàne de la Porte P, Sbarra V, Lombardo D. Association of bile salt-dependent lipase with membranes of human pancreatic microsomes. Eur J Biochem 1995; 233: 209-18.
36. Gjellevik DR, Lombardo D, Walther BJ. Pancreatic bile salt-dependent lipase from cod (Gadus morhua): purification and properties. Biochim Biophys Acta 1992; 1124: 123-34.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
38. Burdette RA, Quinn DM. Interfacial reaction dynamics and acyl-enzyme mechanism for lipoprotein lipase-catalyzed hydrolysis of lipid p-nitrophenyl esters. J Biol Chem 1986; 261: 12016-21.
39. Komaromy MC, Reed M. Expression of rat hepatic lipase in heterologous systems: evidence for different sites for interface binding and catalysis. J Lipid Res 1991; 32: 963-75.
40. Negre-Salvayre A, Abouakil N, Lombardo D, Salvayre R. Hydrolysis of fluorescent pyrene-acyl esters by human pancreatic carboxylic ester hydrolase and bile salt-stimulated lipase. Lipids 1990; 25: 428-34.
41. Li F, Huang Y, Hui DY. Bile salt stimulated cholesterol esterase increases uptake of high density lipoprotein-associated cholesteryl esters by HepG2 cells. Biochemistry 1996; 35: 6657-63.
42. Myers-Payne SC, Hui DY, Brockman HL, Schroeder F. Cholesterol esterase: a cholesterol transfer protein. Biochemistry 1995; 34: 3942-7.
43. Brodt-Eppley J, White P, Jenkins S, Hui DY. Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects. Biochim Biophys Acta 1995; 1272: 69-72.
44. Vorum H, Christensen CK, Pedersen AO, Brodersen R. Fatty acid binding to serum albumin in type I insulin-dependent diabetes mellitus. Acta Diabetol Lat 1991; 28: 1-10.
45. Calvo C, Ulloa N, Del-Pozo R, Verdugo C. Decreased activation of lecithin: cholesterol acyltransferase by glycated apolipoprotein A-I. Eur J Clin Chem Clin Biochem 1993; 31: 217-20.
46. Mackness MI. The human serum paraoxonase polymorphism and atherosclerosis. In: Mackness MI, Clerc M, eds. Esterases, lipases and phospholipases, from structure to clinical significance. New York and London: Plenum Press, 1994: 65-73.